|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 6 (March 15), 2000:
pp. 2015-2023
Tumor-induced apoptosis of T lymphocytes: elucidation of
intracellular apoptotic events
Brian R. Gastman,
Daniel E. Johnson,
Theresa L. Whiteside, and
Hannah Rabinowich
From the Departments of Pathology, Pharmacology, Medicine, and
Otolaryngology, University of Pittsburgh School of Medicine and
University of Pittsburgh Cancer Institute, Pittsburgh, PA.
Our recent studies suggest that human squamous cell carcinoma of the
head and neck (SCCHN) is capable of activating an intrinsic mechanism
of programmed-cell death in interacting lymphocytes in situ and in
vitro. The current study used Jurkat T-cell line as a model to
investigate intracellular apoptotic events in T cells interacting with
SCCHN. Apoptosis induced in T lymphocytes by tumor cells was in part
Fas-mediated, since it was partially, but significantly, inhibited in
the presence of anti-Fas ligand Ab or in Fas-resistant Jurkat cells.
The synthetic caspase inhibitors, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-FMK) and
N-benzyloxycarbonyl-Asp-glu-Val-Asp-fluoromethyl ketone (Z-DEVD-FMK), effectively blocked apoptosis of Jurkat cells co-incubated with SCCHN
cell lines, suggesting the involvement of caspases in tumor-induced apoptosis of lymphocytes. Overexpression of CrmA, an inhibitor of
caspase-1 and caspase-8, partially inhibited tumor-induced T-cell
death. Caspase-8 and caspase-3 were identified as effector molecules in
the execution of tumor-induced T-cell death, since the proform enzymes
were processed into active subunits during co-incubation of T cells
with tumor cells. Furthermore, co-incubation with tumor cells resulted
in cleavage of poly(ADP-ribose) polymerase (PARP), a common caspase-3
substrate, and in cleavage of TcR- chain, shown by us to be a T-cell
specific caspase-3 substrate. Overexpression of Bcl-2 did not provide
protection of T cells from SCCHN-induced DNA degradation. Instead, the
Bcl-2 protein was cleaved in the target T cells during their
co-incubation with tumor cells. These findings demonstrate that tumor
cells can trigger in T lymphocytes caspase-dependent apoptotic
cascades, which are not effectively protected by Bcl-2.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Biswas, K. Biswas, A. Richmond, J. Ko, S. Ghosh, M. Simmons, P. Rayman, B. Rini, I. Gill, C. S. Tannenbaum, et al.
Elevated Levels of Select Gangliosides in T Cells from Renal Cell Carcinoma Patients Is Associated with T Cell Dysfunction
J. Immunol.,
October 15, 2009;
183(8):
5050 - 5058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Carpenito, M. C. Milone, R. Hassan, J. C. Simonet, M. Lakhal, M. M. Suhoski, A. Varela-Rohena, K. M. Haines, D. F. Heitjan, S. M. Albelda, et al.
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
PNAS,
March 3, 2009;
106(9):
3360 - 3365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Das, G. Sa, E. Paszkiewicz-Kozik, C. Hilston, L. Molto, P. Rayman, D. Kudo, K. Biswas, R. M. Bukowski, J. H. Finke, et al.
Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways
J. Immunol.,
April 1, 2008;
180(7):
4687 - 4696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Montes, A. I. Chapoval, J. Nelson, V. Orhue, X. Zhang, D. H. Schulze, S. E. Strome, and B. R. Gastman
Tumor-Induced Senescent T Cells with Suppressor Function: A Potential Form of Tumor Immune Evasion
Cancer Res.,
February 1, 2008;
68(3):
870 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Biswas, A. Richmond, P. Rayman, S. Biswas, M. Thornton, G. Sa, T. Das, R. Zhang, A. Chahlavi, C. S. Tannenbaum, et al.
GM2 Expression in Renal Cell Carcinoma: Potential Role in Tumor-Induced T-Cell Dysfunction.
Cancer Res.,
July 1, 2006;
66(13):
6816 - 6825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Veitonmaki, R. Cao, L.-H. Wu, T. L. Moser, B. Li, S. V. Pizzo, B. Zhivotovsky, and Y. Cao
Endothelial Cell Surface ATP Synthase-Triggered Caspase-Apoptotic Pathway Is Essential for K1-5-Induced Antiangiogenesis
Cancer Res.,
May 15, 2004;
64(10):
3679 - 3686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Murray, P. Symonds, W. Ward, M. Huggins, A. Tiga, K. Rice, Y. M. Heng, I. Todd, and R. A. Robins
Colorectal Cancer Cells Induce Lymphocyte Apoptosis by an Endothelial Monocyte-Activating Polypeptide-II-Dependent Mechanism
J. Immunol.,
January 1, 2004;
172(1):
274 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Molto, P. Rayman, E. Paszkiewicz-Kozik, M. Thornton, L. Reese, J. C. Thomas, T. Das, D. Kudo, R. Bukowski, J. Finke, et al.
The Bcl-2 Transgene Protects T Cells from Renal Cell Carcinoma-mediated Apoptosis
Clin. Cancer Res.,
September 15, 2003;
9(11):
4060 - 4068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kudo, P. Rayman, C. Horton, M. K. Cathcart, R. M. Bukowski, M. Thornton, C. Tannenbaum, and J. H. Finke
Gangliosides Expressed by the Renal Cell Carcinoma Cell Line SK-RC-45 Are Involved in Tumor-induced Apoptosis of T Cells
Cancer Res.,
April 1, 2003;
63(7):
1676 - 1683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Wieckowski, G.-Q. Wang, B. R. Gastman, L. A. Goldstein, and H. Rabinowich
Granzyme B-mediated Degradation of T-Cell Receptor {zeta} Chain
Cancer Res.,
September 1, 2002;
62(17):
4884 - 4889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Bae, Y. Kim, J. C. Park, P.-G. Suh, and S. H. Ryu
The synthetic chemoattractant peptide, Trp-Lys-Tyr-Met-Val-D-Met, enhances monocyte survival via PKC-dependent Akt activation
J. Leukoc. Biol.,
February 1, 2002;
71(2):
329 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Radoja, M. Saio, and A. B. Frey
CD8+ Tumor-Infiltrating Lymphocytes Are Primed for Fas-Mediated Activation-Induced Cell Death But Are Not Apoptotic In Situ
J. Immunol.,
May 15, 2001;
166(10):
6074 - 6083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ferrarini, G. Consogno, P. Rovere, C. Sciorati, L. Dagna, D. Resta, C. Rugarli, and A. A. Manfredi
Inhibition of Caspases Maintains the Antineoplastic Function of {{gamma}}{{delta}} T Cells Repeatedly Challenged with Lymphoma Cells
Cancer Res.,
April 1, 2001;
61(7):
3092 - 3095.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Saito, G. Dworacki, W. Gooding, M. T. Lotze, and T. L. Whiteside
Spontaneous Apoptosis of CD8+ T Lymphocytes in Peripheral Blood of Patients with Advanced Melanoma
Clin. Cancer Res.,
April 1, 2000;
6(4):
1351 - 1364.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G.-Q. Wang, B. R. Gastman, E. Wieckowski, L. A. Goldstein, A. Rabinovitz, X.-M. Yin, and H. Rabinowich
Apoptosis-resistant Mitochondria in T Cells Selected for Resistance to Fas Signaling
J. Biol. Chem.,
January 26, 2001;
276(5):
3610 - 3619.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|